Topic: Neurological disorders
Conditions
Interventions
1. Self-led arm: Identical programme of pelvic floor muscle training to that in the supervised arm but this group will be self-led
2. Supervised arm: Supervised pelvic floor muscle training group exer
Study Entry : Single Randomisation only
Sponsors
North Bristol NHS Trust
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. 18 years or older, NHS patients 2. Primary or secondary progressive MS diagnosis 3. UI, FI or both for at least three months 4. Participants who complete ICIQUI Short Form and report some incontinence (“About once a week or less often” to “All the time” to item 3 ICIQ-UI Short Form), and/or, 5. Participants who complete ICIQ-B and report some incontinence (“Most of the time” to “Never” to items 9, 10 or 11 ICIQ-B 04/08) 6. Cognitive capacity to complete assessments and treatment protocol (Mini Mental State Examination >8) 7. Stable disease over previous 3 months 8. Ability to contract pelvic floor muscles (perineometer response >0) 9. Participants taking LUTS medications can participate if they have been taking the medication at a stable dose for at least three months prior to study enrolment 10. Participants taking Loperamide or bowel relaxation medications can participate if they have been taking the medication at a stable dose for at least three months prior to study enrolment
Exclusion criteria
Exclusion criteria: 1. MS relapse including escalation of symptoms or requiring hospitalization, during the three months prior to the study 2. Introduction of new MS therapies or medications during the three months prior to the study 3. Symptomatic urinary tract infection 4. Indwelling urinary catheter if only reporting urinary incontinence (can be included with catheter if presenting with faecal incontinence for the trial) 5. Pregnancy 6. Vaginal delivery or caesarian section in previous twelve months 7. Pelvic organ prolapse that is visible beyond the intra-oitus on relaxation or cough. 8. Incontinence surgery if undertaken for presenting symptoms (if presenting with faecal incontinence for the trial and incontinence surgery has been undertaken for urinary cause they can be included, and vice versa) 9. Red flag bowel symptoms such as bleeding or recent unexplained change in bowel habit.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Feasibility of the trial; Timepoint(s): Completion of the study. | — |
Countries
United Kingdom
Outcome results
None listed